Trends in initial pharmacological COPD treatment in primary care (2010–2021): a population-based study using the PHARMO Data Network
Shifts in initial pharmacological COPD treatment from 2010 to 2021 likely reflect the introduction of new inhalers and updated management strategies. However, a significant proportion of patients remain without GP prescriptions, which warrants further investigation.
Authors
- Frits M.E. Franssen (ORCID: https://orcid.org/0000-0002-1633-6356)
- Brenda N. Baak
- Martijn A. Spruit (ORCID: https://orcid.org/0000-0003-3822-7430)
- Alda Sofia Pires De Dias Marques (ORCID: https://orcid.org/0000-0003-4980-6200)
- Joana Antão (ORCID: https://orcid.org/0000-0002-2251-4833)
- Qichen Deng (ORCID: https://orcid.org/0000-0003-3835-9142)
- Guilherme Rodrigues (ORCID: https://orcid.org/0000-0002-1483-6912)
Institutions
- Maastricht University Medical Centre (NL)
- Maastricht University (NL)
- Pharmo Institute (NL)
- Ciro (NL)
- University of Aveiro (PT)
Publication Details
- Journal
- Respiratory Research
- Published
- 2024-12-30
- DOI
- https://doi.org/10.1186/s12931-024-03073-w
- Citations
- 3
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 1.26
Funders
- AstraZeneca
- Teva Pharmaceutical Industries
- Universidade de Aveiro
- Fundação para a Ciência e a Tecnologia